Hyperhidrosis: oxybutynin

Study reference

Reason for exclusion

Bergon-Sendin M, Pulido-Perez A, Saez-Martin L C et al. (2016) Preliminary experience with transdermal oxybutynin patches for hyperhidrosis. Actas Dermo-Sifiliograficas 107(10), 845–50

Study not prioritised (not the best available evidence)

Campanati A, Gregoriou S, Kontochristopoulos G, and Offidani A (2015) Oxybutynin for the Treatment of Primary Hyperhidrosis: Current State of the Art. Skin Appendage Disorders 1(1), 6–13

Study not prioritised (not the best available evidence)

Del Boz J , Millan-Cayetano JF, Blazquez-Sanchez N et al. (2016) Individualized dosing of oral oxybutynin for the treatment of primary focal hyperhidrosis in children and teenagers. Pediatric Dermatology 33(3), 327–31

Study not prioritised (not the best available evidence)

Harmsze A M, Houte Mv, Deneer V H et al. (2008) Exercise-induced sweating in healthy subjects as a model to predict a drug's sweat-reducing properties in hyperhydrosis: a prospective, placebo-controlled, double-blind study. Acta Dermato-Venereologica 88(2), 108–12

Study not prioritised (not the best available evidence)

Karlsson-Groth A, Rystedt A, and Swartling C (2015) Treatment of compensatory hyperhidrosis after sympathectomy with botulinum toxin and anticholinergics. Clinical Autonomic Research 25(3), 161–7

Study not prioritised (not the best available evidence)

Kim WO, Kil HK, Yoon KB et al. (2010) Treatment of generalized hyperhidrosis with oxybutynin in post-menopausal patients. Acta Dermato-Venereologica 90(3), 291–3

Study not prioritised (not the best available evidence)

Millan-Cayetano JF, Del Boz J , Rivas-Ruiz F, et al. (2016) Oral oxybutynin for the treatment of hyperhidrosis: outcomes after one-year follow-up. Australasian Journal of Dermatology 30, 30

Study not prioritised (not the best available evidence)

Nicholas R, Quddus A, and Baker DM (2015) Treatment of primary craniofacial hyperhidrosis: a systematic review. American Journal of Clinical Dermatology 16(5), 361–70

Study not prioritised (not the best available evidence)

Stashak AB and Brewer JD (2014) Management of hyperhidrosis. Clinical, and Cosmetic and Investigational Dermatology CCID 7, 285–99

Not a relevant study

Teivelis MP, Wolosker N, Krutman M, et al. (2014) Compensatory hyperhidrosis: Results of pharmacologic treatment with oxybutynin. Annals of Thoracic Surgery 98(5), 1797–802

Study not prioritised (not the best available evidence)

Teivelis MP, Wolosker N, Krutman M, et al. (2014) Treatment of uncommon sites of focal primary hyperhidrosis: experience with pharmacological therapy using oxybutynin. Clinics (Sao Paulo, and Brazil) 69(9), 608–14

Study not prioritised (not the best available evidence)

Wolosker N, Teivelis MP, Krutman M, et al. (2015) Long-term efficacy of oxybutynin for palmar and plantar hyperhidrosis in children younger than 14 years. Pediatric Dermatology 32(5), 663–7

Study not prioritised (not the best available evidence)

Wolosker N, Teivelis MP, Krutman M et al. (2015) Long-term results of the use of oxybutynin for the treatment of plantar hyperhidrosis. International Journal of Dermatology 54(5), 605–11

Study not prioritised (not the best available evidence)

Wolosker N, Teivelis MP, Krutman M et al. (2014) Long-term results of the use of oxybutynin for the treatment of axillary hyperhidrosis. Annals of Vascular Surgery 28(5), 1106–12

Study not prioritised (not the best available evidence)

Wolosker N, Campos JR, Kauffman P et al. (2011) The use of oxybutynin for treating facial hyperhidrosis. Anais Brasileiros de Dermatologia 86(3), 451–6

Study not prioritised (not the best available evidence)

Wolosker N, De Campos JR, Kauffman P et al. (2011) An alternative to treat palmar hyperhidrosis: Use of oxybutynin. Clinical Autonomic Research 21(6), 389–93

Study not prioritised (not the best available evidence)

Wolosker N, De Campos JR, Kauffman P et al. (2011) The use of oxybutynin for treating axillary hyperhidrosis. Annals of Vascular Surgery 25(8), 1057–62

Study not prioritised (not the best available evidence)

Wolosker N, de Campos JR, Kauffman P et al. (2013) Use of oxybutynin for treating plantar hyperhidrosis. International Journal of Dermatology 52(5), 620–3

Study not prioritised (not the best available evidence)

Wolosker N, Krutman M, Kauffman P et al. (2013) Effectiveness of oxybutynin for treatment of hyperhidrosis in overweight and obese patients. Revista Da Associacao Medica Brasileira 59(2), 143–7

Study not prioritised (not the best available evidence)

Wolosker N, Teivelis M P, Krutman M et al. (2014) Long-term results of oxybutynin use in treating facial hyperhidrosis. Anais Brasileiros de Dermatologia 89(6), 912–6

Study not prioritised (not the best available evidence)

Wolosker N, Teivelis MP, Krutman M et al. (2014) Long-term results of oxybutynin treatment for palmar hyperhidrosis. Clinical Autonomic Research 24(6), 297–303

Study not prioritised (not the best available evidence)

Wolosker N, Krutman M, Teivelis MP (2014) Quality of life before hyperhidrosis treatment as a predictive factor for oxybutynin treatment outcomes in palmar and axillary hyperhidrosis. Annals of Vascular Surgery 28(4), 970–6

Study not prioritised (not the best available evidence)